Nicolas Margot

11PUBLICATIONS
13CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyPharmacogenomicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 07, 2026
Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects.

Nina Pennetzdorfer, Vidula Naik, Sally Demirdjian

|Dec 29, 2025
Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.

Onyema Ogbuagu, Andrew Wiznia, Joseph P McGowan

|Apr 14, 2025
Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical Isolates.

Sally Demirdjian, Vidula Naik, Nicolas Margot

|Jan 28, 2025
Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years.

Nicolas A Margot, Vamshi Jogiraju, Nina Pennetzdorfer

|Dec 12, 2023
Cross-resistance to entry inhibitors and lenacapavir resistance through Week 52 in study CAPELLA.

Nicolas Margot, Nina Pennetzdorfer, Vidula Naik

|Dec 08, 2023
Rapid HIV-1 genotyping assay for the detection of capsid mutations.

Nicolas Margot, Vidula Naik, Anurag Nekkalapudi

Pageof 2